Calumet Specialty Products
CLMT
70 hedge funds and large institutions have $274M invested in Calumet Specialty Products in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 9 closing their positions.
56% more call options, than puts
Call options by funds: $31.7M | Put options by funds: $20.3M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
3% less capital invested
Capital invested by funds: $282M → $274M (-$7.85M)
1.21% less ownership
Funds ownership: 21.18% → 19.97% (-1.2%)
3% less funds holding
Funds holding: 72 → 70 (-2)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
15% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.69M |
| 2 |
DMKJ
David M. Knott Jr
|
+$2.42M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.06M |
| 4 |
LPL Financial
San Diego,
California
|
+$863K |
| 5 |
Goldman Sachs
New York
|
+$658K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$6.17M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.08M |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$766K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$709K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$614K |
CLMT Hedge Fund Activity: Q1 2023 in Review
70 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q1 2023, worth a combined $274M — down 2.8% from $282M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CLMT and 8 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 17 added.
The largest buyer was Susquehanna International Group, adding an estimated $2.69M. The largest seller was Morgan Stanley, cutting an estimated $6.17M.
- 70 institutional investors held Calumet Specialty Products (CLMT) as of Q1 2023, down from 72 in Q4 2022.
- Funds reported $274M of Calumet Specialty Products stock for Q1 2023, down 2.8% quarter-over-quarter.
- 8 funds opened new Calumet Specialty Products positions in Q1 2023 and 9 closed out, a net change of -1 holder.
- The largest Calumet Specialty Products buyer in Q1 2023 was Susquehanna International Group, an estimated $2.69M added.
- The largest Calumet Specialty Products seller in Q1 2023 was Morgan Stanley, an estimated $6.17M sold.
Based on aggregated 13F filings for Q1 2023.